Literature DB >> 22329937

Art therapy for terminal cancer patients in a hospice palliative care unit in Taiwan.

Ming-Hwai Lin1, Shwu-Lan Moh, Yu-Cheng Kuo, Pin-Yuan Wu, Chiung-Ling Lin, Mei-Hui Tsai, Tzeng-Ji Chen, Shinn-Jang Hwang.   

Abstract

OBJECTIVE: Even though terminal cancer patients receive help from a hospice palliative care team, they have to suffer the pressure of death with deteriorating conditions. This study aims to evaluate the effect of art therapy for these terminal cancer patients.
METHOD: The patients involved were terminal cancer patients who were under the care of team members, which included physicians, nurses, social workers, clergy, art therapists, and volunteers in a hospice palliative care unit in Taiwan. The art therapy in our study took the form of visual fine art appreciation and hands-on painting. The effects of the art therapy were evaluated according to patients' feelings, cognitions, and behaviors.
RESULTS: There were 177 patients (105 males and 72 females; mean age: 65.4 ±15.8 years) in the study. Each patient received a mean of 2.9 ± 2.0 sessions of the art therapy and produced a mean of 1.8 ± 2.6 pieces of art. During the therapy, most patients described their feelings well, and created art works attentively. Patients expressed these feelings through image appreciation and hands-on painting, among which the landscape was the most common scene in their art. After the therapy, the mean score of patients' artistic expressions (one point to each category: perception of beauty, art appreciation, creativity, hands-on artwork, and the engagement of creating artwork regularly) was 4.0 ± 0.7, significantly higher than the score before therapy (2.2 ± 1.4, p < 0.05). During the therapy, 70% of patients felt much or very much relaxed in their emotional state and 53.1% of patients felt much or very much better physically. SIGNIFICANCE OF
RESULTS: Terminal cancer patients in a hospice palliative care unit in Taiwan may benefit from art therapy through visual art appreciation and hands-on creative artwork.

Entities:  

Mesh:

Year:  2012        PMID: 22329937     DOI: 10.1017/S1478951511000587

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  7 in total

1.  Art therapy based on appreciation of famous paintings and its effect on distress among cancer patients.

Authors:  Jeongshim Lee; Mi Yeon Choi; Yong Bae Kim; Jiyu Sun; Eun Jung Park; Ju Hye Kim; Minchul Kang; Woong Sub Koom
Journal:  Qual Life Res       Date:  2016-12-07       Impact factor: 4.147

Review 2.  Environmental Design for End-of-Life Care: An Integrative Review on Improving the Quality of Life and Managing Symptoms for Patients in Institutional Settings.

Authors:  Rana Sagha Zadeh; Paul Eshelman; Judith Setla; Laura Kennedy; Emily Hon; Aleksa Basara
Journal:  J Pain Symptom Manage       Date:  2017-09-19       Impact factor: 3.612

Review 3.  Art Therapy in Advanced Cancer. A Mapping Review of the Evidence.

Authors:  Nadia Collette; Ivan Sola; Xavier Bonfill; Antonio Pascual
Journal:  Curr Oncol Rep       Date:  2022-08-23       Impact factor: 5.945

4.  Art Making as a Health Intervention: Concept Analysis and Implications for Nursing Interventions.

Authors:  Kyung Soo Kim; Maichou Lor
Journal:  ANS Adv Nurs Sci       Date:  2022-01-11       Impact factor: 2.147

5.  The Influence of a Multimodal Health Program with Diet, Art, and Biofield Therapy on the Quality of Life of People in Japan.

Authors:  Kiyoshi Suzuki; Tomoaki Kimura; Seiya Uchida; Hiroshi Katamura; Hideaki Tanaka
Journal:  J Altern Complement Med       Date:  2019-02-11       Impact factor: 2.579

Review 6.  Mind-body therapies: evidence and implications in advanced oncology practice.

Authors:  Kelley D Mayden
Journal:  J Adv Pract Oncol       Date:  2012-11

7.  Roadmap to Wellness: Exploring Live Customized Music at the Bedside for Hospitalized Children.

Authors:  R Serene Perkins; Maura Boyce; Megan C Byrtek; Regina C Ellis; Cindy Hill; Paul S Fitzpatrick; Shaban Demirel
Journal:  Front Oncol       Date:  2018-02-07       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.